TargetMol

NPC 567 acetate

Product Code:
 
TAR-T21060L
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T21060L-1mg1mg£227.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21060L-5mg5mg£422.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21060L-10mg10mg£589.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21060L-25mg25mg£863.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21060L-50mg50mg£1,179.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21060L-100mg100mg£1,564.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
NPC 567 acetate is a bradykinin B2 antagonist and can be used in studies about the treatment of allergic airway disease.
CAS:
T21060L
Formula:
C62H91N19O15
Molecular Weight:
1342.5
Pathway:
GPCR/G Protein
Purity:
0.9772
SMILES:
N=C(N)NCCC[C@@H](N)C(N[C@@H](CCCNC(N)=N)C(N(CCC1)[C@@H]1C(N2[C@@H](C[C@@H](O)C2)C(NCC(N[C@H](C(N[C@@H](CO)C(N[C@@H](C(N[C@H](C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)CC3=CC=CC=C3)=O)CC4=CC=CC=C4)=O)=O)CC5=CC=CC=C5)=O)=O)=O)=O)=O.CC(O)=O
Target:
Bradykinin Receptor

References

1. Sylvin H, et al. The effect of a bradykinin B2 receptor antagonist, NPC-567, on allergen-induced airway responses in a porcine model. Inflamm Res. 2001 Sep;50(9):453-9. 2. Abraham WM. The potential role of bradykinin antagonists in the treatment of asthma. Agents Actions Suppl. 1992;38 ( Pt 3):439-49.